I-131 therapy for thyroglobulin positive patients without anatomical evidence of persistent disease

Journal of Endocrinological Investigation

Volumn 27, Issue 10, 2004, Pages 949-953

  Kamel, N ^a   Corapcioglu D ^a   Şahin, Mustafa ^a,b   Gursoy A ^a   Kucuk O ^a   Aras, G ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

I 131 posttherapy scan; I 131 whole body scan; Thyroglobulin; Thyroid cancer

Indexed keywords

IODINE 131; THYROGLOBULIN; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; MALE; METASTASIS; RETROSPECTIVE STUDY; THYROID CANCER; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

EID: 12344319565     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347538     Document Type: Article

References (29)

1. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998, 338: 297-306.
2. Solomon BL, Wartofsky L, Burman KD. Current trends in the management of well differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab 1996, 81: 333-9.
3. Hufner M, Stumpf HP, Grussendorf M, Hermann HJ, Kimmig B. A comparison of the effectiveness of 131I whole body scans and plasma Tg determinations in the diagnosis of metastatic differentiated carcinoma of the thyroid: a retrospective study. Acta Endocrinol (Copenh) 1983, 104: 327-32.
4. Maxon HR, Smith HS. Radioiodine-131 in the diagnosis and treatment of metastatic well-differentiated thyroid cancer. Endocrinol Metab Clin North Am 1990, 19: 685-718.
5. Cavalieri RR. Nuclear imaging in the management of thyroid carcinoma. Thyroid 1996, 6: 485-92.
6. Reynold JC, Robbins J. The changing role of radioiodine in the management of differentiated thyroid cancer. Semin Nucl Med. 1997, 27: 152-64.
7. Pacini F, Pinchera A, Giani C, Grasso L, Baschieri L. Serum thyroglobulin concentration and 131-I whole-body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy). Clin Endocrinol (Oxf) 1980, 13: 107-10.
8. Pacini F, Lari R, Mazzeo S, Grasso L, Taddei D, Pinchera A. Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clin Endocrinol (Oxf) 1985, 23: 405-11.
9. Schlumberger M, Baudin E. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. Eur J Endocrinol 1998, 138: 249-52.
10. Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy F, De Groot LJ. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 1994, 79: 98-105.
11. Spencer CA, LoPresti JS, Fatemi S, Nicoloff JT. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement. Thyroid 1999, 9: 435-41.
12. Ashcraft MW, Van Herle AJ. The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer. Am J Med 1981, 71: 806-14.
13. Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 1988, 29: 1790-4.
14. Pacini F, Lippi F, Formica N, et al. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 1987, 28: 1888-91.
15. Schlumberger M, Tubiana M, De Vathaire F, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1986, 63: 960-7.
16. Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 1988, 29: 1790-4.
17. Pineda JD, Lee T, Ain K, Reynolds JC, Robbins J. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan. J Clin Endocrinol Metab 1995, 80: 1488-192.
18. Schlumberger M, Mancusi F, Baudin E, Pacini F. I-131 therapy for elevated thyroglobulin levels. Thyroid 1997, 7: 273-6.
19. Tenenbaum F, Corone C. Schlumberger M, Parmentier C. Thyroglobulin measurement and postablative iodine-131 total body scan after total thyroidectomy for differentiated thyroid carcinoma in patients with no evidence of disease. Eur J Cancer 1996, 32A: 1262.
20. Pacini F, Agate L, Elisei R, et al. Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients. J Clin Endocrinol Metab 2001, 86: 4092-7.
21. McDougall IR. 131I treatment of 131I negative whole body scan, and positive thyroglobulin in differentiated thyroid carcinoma: what is being treated? Thyroid 1997, 7: 669-72.
22. Mazzaferri EL. Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark? J Clin Endocrinol Metab 1995, 80: 1485-17.
23. Wartofsky L, Sherman SI, Gopal J, Schlumberger M, Hay ID. The use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab 1998, 83: 4195-203.
24. Clark OH, Hoelting T. Management of patients with differentiated thyroid cancer who have positive serum thyroglobulin levels and negative radioiodine scans. Thyroid 1994, 4: 501-55.
25. Fatourechi V, Hay ID, Javedan H, Wiseman GA, Mullan BP, Gorman CA. Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer. J Clin Endocrinol Metab 2002, 87: 1521-6.
26. Lubin E, Mechlis-Frish S, Zatz S, et al. Serum thyroglobulin and iodine-131 whole body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nucl Med 1994, 35: 257-62.
27. Cailleux AF, Baudin E, Travagli JP, Ricard M, Schlumberger M. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid carcinoma? J Clin Endocrinol Metab 2000, 85: 175-8.
28. Lazar V, Bidart JM, Caillou B, et al. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 1999, 84: 3228-34.
29. Arturi F, Russo D, Schlumberger M, et al. Iodide symporter gene expression in human thyroid tumors. J Clin Endocrinol Metab 1998, 83: 2493-6.